The Indiana Osteopathic Association passed over a virtually certain $75 million in startup funding from Indiana Wesleyan University
to choose Marian University for its new osteopathic college.
The letter to Indianapolis-based Lilly cites a print advertisement for the antidepressant Cymbalta that did not adequately
display information about the drug’s side effects.
Kevin Stewart stole a computer server that contained the names and confidential information of 900,000 people.
Roche Diagnostics named a new CEO for its North American operations Tuesday to replace Michael Tillmann, who resigned on Friday.
Doctors are pushing again to strengthen their hands in contract negotiations with health insurers, especially market leader
Anthem Blue Cross and Blue Shield.
The long-term outlook for health care reform is uncertain, but many analysts are expecting big health insurers like Indianapolis-based
WellPoint to benefit in 2010.
John J. Greisch was most recently president of international operations at Baxter International Inc.
Attorney General Greg Zoeller says he’ll look at the constitutionality of parts of the federal health care bill, including
the so-called Nebraska compromise.
Lebanon-based hospital system also wants to refinance about $21 million in debt on new medical office building.
State lawmakers say a proposed bill would help people get quicker access to in-home care that most seniors
prefer to nursing homes.
The agency said the meeting was canceled “to allow time for the FDA to review new information” about a proposed new use for
the drug.
So far this year, 35 people have died in Indiana from swine flu.
Legislation set to come out of Washington will not change the most fundamental problems of the health
care system, leaving it up to states, cities and companies to figure out what to do about it.
Legal complaint alleges new $20 million facility in Greenwood breaches partnership deal struck in 2001.
The bill imposes hefty new taxes and coverage rules that will pinch insurers such as WellPoint Inc. by forcing them to cover
more sick people without gaining enough healthy, lower-cost customers, industry insiders say.
Indianapolis health care heavyweights are among those spending $635 million, employing 166 former aides to key congressional
leaders and committees in health reform process.
Eli Lilly and Co. has bought the rights to co-market a new cholesterol-fighting drug in the U.S., giving it a third heart drug for sales personnel
to push.
The Senate has passed President Barack Obama’s landmark health care overhaul in a climactic Christmas Eve vote, extending
medical insurance to 30 million Americans. But the Senate’s bill still must be merged with legislation passed by the House,
and there are significant differences.
Another year of rapid change at Eli Lilly and Co. did little to move the company out from under the cloud cast by its best-selling
drug, Zyprexa.
Congress is on the cusp of transforming health insurance—if it can pass a health reform bill that was losing popularity
late in the year.
